CD274 and neoplasm: Results showed that 116 (10 mg/kg) caused no significant weight loss, indicating a good safety profile and displayed a tumor growth inhibition value of 65.1%, which was raised to 77.6% when combined with PD-L1 inhibitor (10mg/kg) [105].